𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN12 IMPACT OF INNOVATIVE AND EXPENSIVE THERAPIES IN THE TREATMENT OF METASTATIC BREAST CANCER (MBC): FOCUS ON TRASTUZUMAB (HERCEPTIN(H))

✍ Scribed by H Miadi-Fargier; V Trillet-Lenoir; C Ganne; S Couray-Targe; C Colin

Book ID: 119592353
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 64 KB
Volume: 5
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61428-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN97 TREATMENT OF PATIENTS WITH METASTA

PCN97 TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER (MBC) IN THE UKWHO PROGRESS ON TRASTUZUMAB AND HAVE PREVIOUSLY RECEIVED AN ANTHRACYCLINE AND ATAXANE: A NEED FOR EVIDENCE BASED THERAPIES?

✍ M Walker; J Unwin; C Relf; D Browning; M Amonkar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PCN97 A COST-UTILITY ANALYSIS ON THE USE

PCN97 A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB + ANASTROZOLE COMPARED TO LAPATINIB + LETROZOLE, LETROZOLE MONOTHERAPY OR ANASTROZOLE MONOTHERAPY IN THE TREATMENT OF HER2+/HORMONE RECEPTOR POSITIVE (HR+) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

✍ S McNamara; L Moore; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB